Clinically applicable pan-etiology HCC risk biomarker was established Global transcriptome map of cirrhosis identified HCC chemoprevention targets Global transcriptome map of cirrhosis identified clinically relevant animal models LPA pathway inhibitors were verified as HCC chemopreventive and anti-fibrotic drugs